Navigation Links
Will Lipodissolve Continue to Remain Popular?
Date:12/12/2007

Leading Dermatologist Doing His Part to Warn Consumers

OMAHA, Neb., Dec. 12 /PRNewswire/ -- Lipodissolve, a treatment for unwanted fat, has been in the news for the past several years with significant controversy about its effectiveness and safety. Now, Fig, the parent company for up to 18 facilities around the country that offer this treatment and defender of this procedure, has closed its stores and is considering declaring bankruptcy. This is in addition to a longtime 'unsatisfactory' rating by the St. Louis Better Business Bureau, with 102 complaints over a year's period.

Despite the closure of this company, there are many companies still selling the non FDA approved substance, PC/DC, which is used for this procedure. Joel Schlessinger, M.D., Board-Certified Dermatologist and Board-Certified General Cosmetic Surgeon and immediate past-president of the American Society of Cosmetic Dermatology and Aesthetic Surgery (ASCDAS), has been involved in spotlighting the dangers of treatment. He is also involved in efforts to stop this treatment from being performed in his state, Nebraska. Just Monday, December 10th, Kansas enacted stricter restrictions on this procedure.

"It doesn't surprise me that Fig closed down -- the handwriting was on the wall when they received the unsatisfactory rating from the BBB. While I've been working on the Lipodissolve issue, many people have sustained harm from this unapproved procedure. Now, countless people have lost their money without any recourse due to the financial uncertainty of this company," says Schlessinger.

"Patient safety shouldn't be put in jeopardy for the sake of making a profit," said Joel Schlessinger M.D., founder of LovelySkin.com. "I've seen half a dozen cases of patients who received treatments and then had pain, swelling, bruising, bloating in the treatment areas, irregular dimpling and divots in the skin. Hopefully, this closure will stop some of this from happening."

<
'/>"/>
SOURCE Joel Schlessinger M.D.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Lipodissolve - Is it Safe???
2. Battle Continues Over Vietnam PTSD Numbers
3. Continued Statin Use Boosts Post-Stroke Outcomes
4. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
5. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
6. Securians Minnesota Life Continues to Climb Group Life Rankings
7. USA TODAY Continues Spirit of the USA Charity Program as Part of Newspapers 25th Anniversary Celebration
8. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
9. United States continues to have highest level of health spending
10. LehmanMillet Continues Expansion with Strategic Hires
11. Pink Ribbon Bagels Continue the Fight for a Cure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... issue of Experimental Biology and Medicine ... Gaskins and Paul Kenis in the Institute of ... University of Illinois Urbana-Champaign describe their recent work ... a variety of cell functions including energy metabolism, ... roles in regulating normal cellular behavior, redox status ...
(Date:4/17/2014)... AURORA, Colo. (April 17, 2014) Two recent ... Medicine researcher and colleagues may help scientists develop ... virus, Yellow fever, Japanese encephalitis and other disease-causing ... of biochemistry and molecular genetics at the School ... the Howard Hughes Medical Institute, and colleagues recently ...
(Date:4/17/2014)... Bonheur Children,s Hospital Pediatrician-in-Chief Jon McCullers, MD, was ... April issue of Nature Reviews Microbiology , ... Dr. McCullers, a world-renowned infectious disease specialist, and ... University of Tennessee Health Science Center, analyzed the ... 1957 and 1968 pandemics, as well as more ...
(Date:4/17/2014)... personnel who served in Iraq and Afghanistan and ... (TBI) were compared to military personnel without TBI ... in measures of overall disability, cognitive function, post-traumatic ... reported in an article in Journal of ... Liebert, Inc., publishers. The article is available free ...
(Date:4/17/2014)... as 10 million older Americans suffer from depression, often ... However, new research a project that followed the ... years found that Internet use among the elderly ... 30 percent. , "That,s a very strong effect," said ... information studies and media who led the project. "And ...
Breaking Medicine News(10 mins):Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Internet use can help ward off depression among elderly 2
... researchers have discovered a new method to test for ... for chromosomal abnormalities are currently done through amniocentesis and ... scientists have been able to isolate single cells of ... woman with the help of a cervical swab. This ...
... delay your chances of getting treated// for cancer early. ... of Cancer, valuable time is lost when cancer patients goes ... suspected prostate cancer might be diagnosed three times later than ... gets treated for cancer. The average time for the diagnosis ...
... of inability to read in dyslexic children is// not ... thought in recent years. Instead, the dyslexic children may ... ,Dyslexia is one type of specific learning disability. ... verbal skills, abstract reasoning, hand-eye coordination, concentration, perception, memory ...
... School of Medicine have successfully discovered how the body’s ... like leprosy in some cases but not in others. ... system often fights with the infections in the initial ... they are unable to control the bug that it ...
... suffering from chronic lower back pain for more than a ... is done when no other treatment seems to bring them ... British Medical Journal reveled that in the long run this ... do not have enough finance to sustain a long-term medical ...
... sleep apnea syndrome affects a lot of people who ... top of having a difficult night, these people may ... ,Obstructive sleep apnea syndrome (OSAS), also known as ... heart problems, stroke, obesity, breathing problems, sexual dysfunction and ...
Cached Medicine News:
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... approval condition to the announced tender offer for all of the ... a result of the waiver, the transaction is no longer conditional ... on January 24, 2014 following the currently scheduled expiration time, subject ...
(Date:1/15/2014)... YORK , January 15, 2014 ... Ltd., the exclusive worldwide distributor of highly sophisticated agro-breeding ... on January 7, 2014, the Company,s board of directors ... Weiner as its new member of the board. ...
(Date:1/15/2014)... an unprecedented effort to curb the spread of "superbugs" such as ... an advanced and portable UV germicidal lamp manufactured by MRSA-UV is ... In order to prevent EMS paramedics and transport patients ... Palm Beach Fire Rescue is the first in the ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Superbugs No Longer Ride In Rescue Vehicles 2
... Combination Clinical Trials ... SOUTH SAN FRANCISCO, Calif., June 16 Sunesis,Pharmaceuticals, Inc. (Nasdaq: ... the company,s lead drug candidate, voreloxin (formerly,SNS-595), including updated results ... single agent in relapsed or refractory patients with acute,myeloid leukemia ...
... Requip XL Improved Symptoms in Patients Not Optimally ... "Off" Time by Nearly Two Hours Per Day, ... (NYSE: GSK ) today announced the approval ... for the treatment,of the signs and symptoms of ...
Cached Medicine Technology:Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 2Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 3Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 4Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 5Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 6U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease 2U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease 3U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease 4U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease 5
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: